Diaceutics Plc Stock Performance
| DIUXF Stock | USD 1.37 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Diaceutics PLC are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Diaceutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Diaceutics PLC is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 25.3 M | |
| Total Cashflows From Investing Activities | -5.6 M |
Diaceutics |
Diaceutics PLC Relative Risk vs. Return Landscape
If you would invest 137.00 in Diaceutics PLC on October 5, 2025 and sell it today you would earn a total of 0.00 from holding Diaceutics PLC or generate 0.0% return on investment over 90 days. Diaceutics PLC is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Diaceutics, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Diaceutics PLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diaceutics PLC's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Diaceutics PLC, and traders can use it to determine the average amount a Diaceutics PLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DIUXF |
Based on monthly moving average Diaceutics PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Diaceutics PLC by adding Diaceutics PLC to a well-diversified portfolio.
Diaceutics PLC Fundamentals Growth
Diaceutics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Diaceutics PLC, and Diaceutics PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Diaceutics Pink Sheet performance.
| Return On Equity | 0.0032 | |||
| Return On Asset | 3.0E-4 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 54.7 M | |||
| Shares Outstanding | 84.47 M | |||
| Price To Earning | 112.00 X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 6.10 X | |||
| Revenue | 13.94 M | |||
| EBITDA | 2.35 M | |||
| Cash And Equivalents | 19.68 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 1.56 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | 570 K | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 45.01 M | |||
About Diaceutics PLC Performance
By analyzing Diaceutics PLC's fundamental ratios, stakeholders can gain valuable insights into Diaceutics PLC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Diaceutics PLC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Diaceutics PLC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.Things to note about Diaceutics PLC performance evaluation
Checking the ongoing alerts about Diaceutics PLC for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Diaceutics PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Diaceutics PLC generated a negative expected return over the last 90 days | |
| Diaceutics PLC may become a speculative penny stock | |
| About 47.0% of the company shares are held by company insiders |
- Analyzing Diaceutics PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Diaceutics PLC's stock is overvalued or undervalued compared to its peers.
- Examining Diaceutics PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Diaceutics PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Diaceutics PLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Diaceutics PLC's pink sheet. These opinions can provide insight into Diaceutics PLC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Diaceutics Pink Sheet analysis
When running Diaceutics PLC's price analysis, check to measure Diaceutics PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diaceutics PLC is operating at the current time. Most of Diaceutics PLC's value examination focuses on studying past and present price action to predict the probability of Diaceutics PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diaceutics PLC's price. Additionally, you may evaluate how the addition of Diaceutics PLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |